Skip to main content
Patients Referrer
 
Book Online Call Now Modify Booking
Image
 Dr Matthew Fielder

Dr Matthew
Fielder

MBBS LLB (Hons), BSc (Mathematics), FRANZCR, FAANMS
Specialties and interests
  • Nuclear medicine
  • Neurodegenerative Imaging and Theranostics
About

Dr Matthew Fielder is a dual-trained Consultant Radiologist and Nuclear Medicine Specialist at Qscan Radiology Clinics, based across our North Brisbane clinics. He will be consulting on Mondays, Tuesdays and Wednesdays, commencing 5 January 2026.

Dr Fielder graduated with his Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Queensland in 2015, following earlier degrees including a Bachelor of Science (Mathematics) in 2007 and a Bachelor of Laws (Honours) in 2009.

He completed his specialist training in radiology and nuclear medicine at Sunshine Coast University Hospital and the Royal Brisbane and Women’s Hospital. Dr Fielder has a strong clinical interest in neurodegenerative imaging and theranostics.

Fellowships
  • Nuclear Medicine, Sunshine Coast University Hospital and Royal Brisbane & Women's Hospital 

News & Articles

 

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.